Hydrophobic Matrices
Hydrophobic Matrices - Related Videos
11:38
Preparation of Complaint Matrices for Quantifying Cellular Contraction
0 Views •
Cited by 115 •
2010
In this video, we demonstrate the experimental techniques used to fabricate compliant, extracellular matrix (ECM) coated substrates suitable for cell culture, and which are amenable to traction force microscopy and observing effects of ECM stiffness on cell behavior.
07:58
Invasion Assay Using 3D Matrices
0 Views •
2023
The extracellular matrix (ECM) is a network of molecules that provide a structural framework for cells and tissues and helps facilitate intercellular communication. Three-dimensional cell culture techniques have been developed to more accurately model this extracellular environment for in vitro study. While many cell processes during migration through 3D matrices are similar to those required for movement across rigid 2D surfaces, including adherence, migration through ECM also requires cells...
03:22
Calcium-Dependent Hydrophobic Interaction Chromatography: A Technique to Purify Calcium-Binding Proteins Based on Hydrophobic Interactions
0 Views •
2025
In this video, we demonstrate the purification of calcium-binding protein from a dialyzed cell lysate through calcium-dependent hydrophobic interaction chromatography. The calcium-binding proteins expose a hydrophobic region upon binding with calcium, facilitating interaction with a hydrophobic group on resin. Later these proteins are eluted using calcium chelator EDTA that reverses the interaction.
03:46
Butyl-Dependant Hydrophobic Interaction Liquid Chromatography: A Technique to Characterize Antibody-Drug Conjugates Based on Hydrophobic Interactions
0 Views •
2025
This video demonstrates the hydrophobic interaction liquid chromatography-based characterization of antibody-drug conjugates. Using a butyl ligand-based chromatography column, the antibody-drug conjugates are characterized via hydrophobic interactions with the ligand.
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
0 Views •
Cited by 5 •
2014
The BoTest Matrix botulinum neurotoxin (BoNT) detection assays rapidly purify and quantify BoNT from a range of sample matrices. Here, we present a protocol for the detection and quantification of BoNT from both solid and liquid matrices and demonstrate the assay with BOTOX, tomatoes, and milk.
FAQs
High-salt conditions promote the exposure and association of hydrophobic regions on proteins, increasing their interaction with hydrophobic ligands attached to the matrix. This controlled change in molecular behavior allows selected proteins to bind while other components remain less strongly associated. In clinical research and bioprocessing, the effect provides the basis for selective separation rather than nonspecific capture.
Bound proteins are released when the salt concentration is reduced or when suitable modifiers are added. These changes weaken the conditions that favored exposure and association of hydrophobic surfaces, allowing molecules to dissociate from the ligands. Researchers can therefore adjust elution conditions to recover target proteins after binding, supporting purification workflows that aim to retain biological activity.
Compatibility with aqueous processing is important because the workflow can operate in water-based conditions while helping preserve the biological activity of purified molecules. That feature is relevant to proteins, antibodies, vaccines, and diagnostic reagents, where preserving biological activity is important. In clinical workflows, aqueous handling also fits the processing environment described for research and bioprocessing.
A basic workflow first applies high-salt conditions to promote protein binding to hydrophobic ligands. The matrix then retains molecules that associate under those conditions, after which reducing salt concentration or adding a suitable modifier releases the bound material. This sequence connects application, selective retention, and recovery in one process, making it adaptable to protein purification in clinical research and bioprocessing.
The approach is relevant to purification of therapeutic proteins, antibodies, vaccines, and diagnostic reagents. In these settings, the matrix contributes selective separation within workflows designed to recover biologically active material. Its use spans clinical research and pharmaceutical manufacturing, so the same underlying separation principle can support both laboratory-scale investigations and broader bioprocessing activities.
Selectivity helps distinguish desired biomolecules during purification, while scalability supports movement from clinical research or laboratory workflows toward pharmaceutical manufacturing. Together with compatibility with aqueous processing, these properties make hydrophobic matrices useful when a process must separate relevant products and maintain suitable handling conditions across different operational settings. The outcome is a practical platform for clinical bioprocessing.